Dr Nour Abahadra of Memorial Sloan Kettering discusses the diagnosis, treatment, and management of metastatic triple negative breast cancer (TNBC). Patient guest, Shay Elkins, shares her experience, ...
The order of cancer-driving mutations—genetic changes—plays an important role in whether tumors in the intestine can develop, new research reveals. These are the findings published on 3 December in ...
Substantial and sustained weight loss has been linked to a reduced risk of cancer and cancer-related death, mainly in women. Two new studies now provide clues to why the risk is reduced—and suggest ...
A randomized, noninferiority study of recombinant human G-CSF/human serum albumin fusion (CG-10639) and pegfilgrastim in breast cancer patients receiving myelosuppressive therapy. This is an ASCO ...
Scientists at the Broad Institute of MIT and Harvard, Massachusetts General Hospital (MGH), and Harvard Medical School, in partnership with IBM Research and health technology company Color, say they ...
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers We examined women undergoing breast MRI in the Breast Cancer Surveillance Consortium ...
Dying cancer patients from ethnic minority backgrounds are experiencing significant disparities in end-of-life care, a new study has revealed. The research indicates that individuals from Black, South ...
I just hit my 5-year breast cancer remission anniversary. These are the 4 hard things no one told me about being a survivor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results